Yongping Cui

797 total citations · 1 hit paper
10 papers, 437 citations indexed

About

Yongping Cui is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yongping Cui has authored 10 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Surgery. Recurrent topics in Yongping Cui's work include Cancer-related gene regulation (3 papers), RNA modifications and cancer (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Yongping Cui is often cited by papers focused on Cancer-related gene regulation (3 papers), RNA modifications and cancer (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Yongping Cui collaborates with scholars based in China, Hong Kong and United States. Yongping Cui's co-authors include Li Zhou, Na Xie, Canhua Huang, Edouard C. Nice, Tao Zhang, Zhe Zhang, Heyang Cui, Yueguang Wu, Yan Dong and Huijuan Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Letters and Signal Transduction and Targeted Therapy.

In The Last Decade

Yongping Cui

9 papers receiving 433 citations

Hit Papers

Overcoming cancer therapeutic bottleneck by drug repurposing 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongping Cui China 5 228 99 65 56 41 10 437
Tolou Shadbahr Finland 2 230 1.0× 94 0.9× 72 1.1× 42 0.8× 42 1.0× 2 385
Xiuhua Wu China 10 230 1.0× 76 0.8× 28 0.4× 35 0.6× 23 0.6× 11 442
Yunjiang Zhou China 15 420 1.8× 145 1.5× 34 0.5× 72 1.3× 62 1.5× 22 640
Yudong Wang China 13 358 1.6× 70 0.7× 71 1.1× 122 2.2× 37 0.9× 28 563
Junmei Hou China 5 302 1.3× 109 1.1× 32 0.5× 95 1.7× 44 1.1× 5 502
Elin Lindhagen Sweden 14 245 1.1× 138 1.4× 24 0.4× 67 1.2× 35 0.9× 28 505
Hossain Ahmed Bangladesh 3 210 0.9× 136 1.4× 18 0.3× 85 1.5× 37 0.9× 6 450
Lei Lou China 13 274 1.2× 80 0.8× 29 0.4× 97 1.7× 28 0.7× 35 431
Sarah Mackenzie United States 12 408 1.8× 116 1.2× 29 0.4× 55 1.0× 51 1.2× 20 628
Santosh Kumar Behera India 7 188 0.8× 87 0.9× 24 0.4× 105 1.9× 56 1.4× 26 434

Countries citing papers authored by Yongping Cui

Since Specialization
Citations

This map shows the geographic impact of Yongping Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongping Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongping Cui more than expected).

Fields of papers citing papers by Yongping Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongping Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongping Cui. The network helps show where Yongping Cui may publish in the future.

Co-authorship network of co-authors of Yongping Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Yongping Cui. A scholar is included among the top collaborators of Yongping Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongping Cui. Yongping Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gao, Mingwei, Xuehan Zhuang, Yueguang Wu, et al.. (2025). Evolutionary adaptation and asymmetric inheritance of polyploid giant cancer cells in esophageal squamous cell carcinoma. Cancer Letters. 630. 217818–217818. 4 indexed citations
2.
Zhang, Li, Mingwei Gao, Yueguang Wu, et al.. (2024). MST1 interactomes profiling across cell death in esophageal squamous cell carcinoma. SHILAP Revista de lepidopterología. 4(6). 531–543. 2 indexed citations
3.
Zhuang, Xuehan, Rui Ye, Yong Zhou, et al.. (2024). Leveraging new methods for comprehensive characterization of mitochondrial DNA in esophageal squamous cell carcinoma. Genome Medicine. 16(1). 50–50. 4 indexed citations
4.
Wu, Yueguang, Ning Ding, Yan Zhou, et al.. (2024). Three-dimensional characteristics of T cells and vasculature in the development of mouse esophageal cancer. iScience. 27(12). 111380–111380.
5.
Ding, Ning, Yikun Cheng, Huijuan Liu, et al.. (2023). Fusobacterium nucleatum Infection Induces Malignant Proliferation of Esophageal Squamous Cell Carcinoma Cell by Putrescine Production. Microbiology Spectrum. 11(2). e0275922–e0275922. 17 indexed citations
6.
Wei, Wenqing, Qinglan Li, Yuhao Liu, et al.. (2022). Comprehensive characterization of posttranscriptional impairment-related 3′-UTR mutations in 2413 whole genomes of cancer patients. npj Genomic Medicine. 7(1). 34–34. 9 indexed citations
7.
Wang, Fang, Caixia Cheng, Xinhui Wang, et al.. (2022). Elevated FAM84B promotes cell proliferation via interacting with NPM1 in esophageal squamous cell carcinoma. Cell Death Discovery. 8(1). 182–182. 2 indexed citations
8.
Chen, Cheng, Heyang Cui, Huijuan Liu, et al.. (2022). Role of Epidermal Growth Factor Receptor-Specific CAR-T Cells in the Suppression of Esophageal Squamous Cell Carcinoma. Cancers. 14(24). 6021–6021. 1 indexed citations
9.
Zhang, Zhe, Li Zhou, Na Xie, et al.. (2020). Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduction and Targeted Therapy. 5(1). 113–113. 379 indexed citations breakdown →
10.
Wang, Yu, Guangchao Wang, Yan Wang, et al.. (2019). FAT1, a direct transcriptional target of E2F1, suppresses cell proliferation, migration and invasion in esophageal squamous cell carcinoma. Chinese Journal of Cancer Research. 31(4). 609–619. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026